Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
NCT ID: NCT00782314
Last Updated: 2009-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2008-04-30
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma
NCT02224157
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306
Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy
NCT01711840
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.
NCT02149199
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00385593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
patients with maintenance only treatment with Symbicort Turbuhaler for at least 1 month
No interventions assigned to this group
2
patients with SMART treatment with Symbicort Turbuhaler for at least 1 month
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-pregnant females
* existing maintenance only treatment with Symbicort® Turbuhaler® 80 μg/4,5 μg, 160 μg/4,5 μg or 320 μg/9 μg for at least 1 month
* existing SMART treatment with Symbicort® Turbuhaler® 80 μg/4,5 μg or 160 μg /4,5 μg for at least 1 month
Exclusion Criteria
* patients treated with Symbicort® Turbuhaler® for COPD
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca UK Limited, Branch Office in Slovenia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Igor Koren, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
Radix - medicinske storitve, Igor Koren s.p.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Celje, Celje, Slovenia
Research Site
Dvorec Sela, Dvorec Sela, Slovenia
Research Site
Grosuplje, Grosuplje, Slovenia
Research Site
Idrija, Idrija, Slovenia
Research Site
Izola, Izola, Slovenia
Research Site
Jesenice, Jesenice, Slovenia
Research Site
Kamnik-Duplica, Kamnik-Duplica, Slovenia
Research Site
Kranj, Kranj, Slovenia
Research Site
Litija, Litija, Slovenia
Research Site
Ljubljana, Ljubljana, Slovenia
Research Site
Lucija, Lucija, Slovenia
Research Site
Maribor, Maribor City Municipality, Slovenia
Research Site
Novo Mesto, Mestna Občina Novo mesto, Slovenia
Research Site
Murska Sobota, Murska Sobota, Slovenia
Research Site
Domžale, Občina Domžale, Slovenia
Research Site
Ravne na Koroškem, Občina Ravne na Koroškem, Slovenia
Research Site
Sežana, Občina Sežana, Slovenia
Research Site
Ptuja, Ptuja, Slovenia
Research Site
Slovenj Gradec, Slovenj Gradec, Slovenia
Research Site
Slovenska Bistrica, Slovenska Bistrica, Slovenia
Research Site
Topolšica, Topolsica, Slovenia
Research Site
Velenje, Velenje, Slovenia
Research Site
Vrhnika, Vrhnika, Slovenia
Research Site
Zagorje, Zagorje, Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-RSI-SYM-2008/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.